In contrast, we found a significantly higher expression of IFNB1 and IFNL2 as well as downstream signalling in mtp53 cancers as compared to wtp53 cancers by analysing all human breast cancer RNA-Seq data in TCGA. This evidence concerns the gene IFNL2 and breast cancer.